Sleep Apnea Rarely Investigated in Older Adults

Share this content:
Sleep Apnea Rarely Investigated in Older Adults
Sleep Apnea Rarely Investigated in Older Adults

WEDNESDAY, May 16, 2018 (HealthDay News) -- A high risk of obstructive sleep apnea (OSA) is common among older adults but is seldom investigated, though when it is investigated, it is almost always confirmed, according to a study published online May 9 in the Journal of the American Geriatrics Society.

Tiffany J. Braley, M.D., from the University of Michigan in Ann Arbor, and colleagues assessed the rate of evaluation, diagnosis, and treatment of OSA among 1,052 community-dwelling older adults participating in the National Health and Aging Trends Study who were at risk for the condition.

The researchers found that 56 percent of the participants who completed the sleep module were estimated to be at high risk of OSA. However, of these high-risk individuals, only 8 percent had been tested for OSA. Of those tested, 94 percent were diagnosed with OSA and 82 percent of those diagnosed were prescribed treatment with positive airway pressure.

"These findings suggest a significant gap in OSA assessment for older Americans that could have public health implications," the authors write.

Two authors disclosed financial ties to biotechnology and medical device companies.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Access to In-Home Support Soon to Be Available for Seniors

Access to In-Home Support Soon to Be Available ...

Under Medicare Advantage, a health-related reason will be needed to qualify; costs will vary

USPSTF Recommends Screening Adults for Unhealthy Alcohol Use

USPSTF Recommends Screening Adults for Unhealthy Alcohol Use

Recommendation applies to all adults, including pregnant women; insufficient evidence for teens

AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides

AHA: Icosapent Ethyl Cuts CV Risk From Elevated ...

Ischemic events reduced among patients with elevated triglycerides despite taking statins

is free, fast, and customized just for you!




Already a member?

Sign In Now »